QuickView for 3%275%27-cyclic nucleotide phosphodiesterase%2C catalytic domain (biogroup)

1. L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
2. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
4. L1000 CMAP - Non-small cell lung cancer A549.311 cells with CRISPR targeted gene knockouts
5. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens

There were no matches for 3%275%27-cyclic nucleotide phosphodiesterase%2C catalytic domain

There were no clinical trials for 3%275%27-cyclic nucleotide phosphodiesterase%2C catalytic domain